Many stocks remain expensive even though the stock market has lost much of its momentum from earlier this year. Most bank stocks have been hammered in 2023 by the banking crisis that erupted earlier this year. Bank of America (NYSE: BAC) is no exception.
Before buying this beaten-down stock, gaining valuable knowledge about its operations is a good idea.
BioNTech (NASDAQ: BNTX) has turned in a dismal performance so far this year. The average analysts' price target reflects an upside potential of 56%. Granted, not every analyst is all that bullish about BioNTech.